Carangue, R-v John C.
HRN: 08-45-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2023
CEFUROXIME 750MG (VIAL)
05/01/2023
05/08/2023
IV
800mg
Q8hrs
Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes